Biocon [BIOCON] vs GlaxoSmithKline [GLAXO] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: Biocon wins in 5 metrics, GlaxoSmithKline wins in 8 metrics, with 0 ties. GlaxoSmithKline appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBioconGlaxoSmithKlineBetter
P/E Ratio (TTM)47.1957.47Biocon
Price-to-Book Ratio2.2127.25Biocon
Debt-to-Equity Ratio66.260.51GlaxoSmithKline
PEG Ratio40.2054.20Biocon
EV/EBITDA20.0047.63Biocon
Profit Margin6.64%24.74%GlaxoSmithKline
Operating Margin15.98%33.07%GlaxoSmithKline
EBITDA Margin15.98%33.07%GlaxoSmithKline
Return on Equity5.40%49.75%GlaxoSmithKline
Return on Assets1.68%18.17%GlaxoSmithKline
Free Cash Flow$17.18B$12.65BBiocon
Dividend Yield0.26%1.65%GlaxoSmithKline
1-Year Return18.96%22.81%GlaxoSmithKline
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Biocon vs GlaxoSmithKline Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Biocon vs GlaxoSmithKline Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...